* Max Healthcare's Q2 revenue grew by 21% year-on-year, and operating EBITDA increased by 23%, marking 20 consecutive quarters of growth. * Existing Units achieved revenue growth of 14% and EBITDA growth of 19%. * A new 268-bed brownfield tower at Nanavati-Max is set to be commissioned this week, and a new 400-bed brownfield tower at Max Smart will be ready for commissioning within the next 30 days. * Divestment of hospitals in Chitta and Anoopshahr was completed in September 2025. * Merger of two wholly-owned subsidiaries resulted in a one-time benefit of ₹149 crore during the quarter. * CGHS revised prices effective October 13th, expecting a favourable impact of over ₹200 crore once fully implemented. * Insurance renewals issues have been resolved. * Network gross revenue stood at ₹2,692 crore, up 21% year-on-year. * Network operating EBITDA stood at ₹694 crore, up 23% year-on-year. * Profit after tax (PAT) for the Network was ₹554 crore, including a one-time tax impact of ₹149 crore. * The Network generated free cash flows of ₹291 crore during the quarter. * International patient revenue reached ₹231 crore, registering a growth of 25% year-on-year. * Max@Home reported revenue of ₹63 crore, reflecting a 20% year-on-year growth, and Max Lab reported revenue of ₹54 crore, reflecting a 16% year-on-year growth. * Expansion projects are progressing at Max Lucknow, Sector 56 Gurgaon, Max Nagpur, Patparganj, Max Vikrant (Saket), Zirakpur, Mohali, Max Vaishali and Thane. The project at Patparganj is expected to be completed by FY'28. * Network gross revenue for H1 FY26 stood at ₹5,266 crore, reflecting a growth of 24% year-on-year. * Overall Network operating EBITDA for H1 FY26 grew by 23% year-on-year to ₹1,308 crore. * The company provided free treatment to approximately 44,000 patients from economically weaker sections of the society, worth ₹61 crore at hospital tariff.
